-+ 0.00%
-+ 0.00%
-+ 0.00%

MEDICUS PHARMA PROVIDES UPDATE ON SKNJCT-003 PHASE 2 CLINICAL STUDY FOR THE TREATMENT OF NODULAR BASAL CELL CARCINOMA (BCC)

Reuters·02/14/2025 12:30:00

Please log in to view news